Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide

Cited by (238)

Items 101–200 of 238

1. Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression.
   Zhongling Zhu, Shuangshuang Du, Fengxia Ding, Shanshan Guo, Guoguang Ying, Yan Zhao · 2016 · Europe PMC (PubMed Central)
2. Quercetin and chloroquine synergistically kill glioma cells by inducing organelle stress and disrupting Ca2+ homeostasis
   Eunjung Jang, In Young Kim, Heeyeon Kim, Dong Min Lee, Dong Young Seo, Ju Ahn Lee, Kyeong Sook Choi, Eunhee Kim · 2020 · Biochemical Pharmacology
3. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis
   Lixin Wu, Xuqiang Zhu, Zhenyu Song, Mengguo Guo, Junxin Liang, Dongming Yan · 2020 · Life Sciences
4. Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition
   Narges K. Gortany, Ghodratollah Panahi, Homanaz Ghafari, Maryam Shekari, Mahmoud Ghazi‐Khansari · 2021 · Cancer Chemotherapy and Pharmacology
5. The Potential of Combi-Molecules with DNA-Damaging Function as Anticancer Agents
   Guohui Sun, Tengjiao Fan, Lijiao Zhao, Yue Zhou, Rugang Zhong · 2017 · Future Medicinal Chemistry
6. Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach
   Srishti Agarwal, Priyadharshni Muniyandi, Toru Maekawa, D. Sakthi Kumar · 2018 · International Journal of Pharmaceutics
7. Triggering of endoplasmic reticulum stress via ATF4-SPHK1 signaling promotes glioblastoma invasion and chemoresistance
   Beiwu Lan, Zhoudao Zhuang, Jinnan Zhang, Yichun He, Nan Wang, Zhuoyue Deng, Lin Mei, Yan Li, Yufei Gao · 2024 · Cell Death and Disease
8. Deubiquitinating enzyme 4 facilitates chemoresistance in glioblastoma by inhibiting P53 activity
   Na Qin, Fengli Han, Li Li, Yingwei Ge, Wei Jen Lin, Jiang Wang, Lin Wu, Gang Zhao, Yanchun Deng, Jian Zhang · 2018 · Oncology Letters
9. Volatile Oil of Acori Graminei Rhizoma-Induced Apoptosis and Autophagy are dependent on p53 Status in Human Glioma Cells
   Lu Chen, Zhuyun Jiang, Hui Ma, Ling Gui Ning, Hongdan Chen, Li Li, Hongyi Qi · 2016 · Scientific Reports
10. Carboranylanilinoquinazoline EGFR-Inhibitors: Toward ‘Lead-to-Candidate’ Stage in the Drug-Development Pipeline
    Marcos Couto, Catalina Alamón, Carina Sánchez, Belén Dávila, Marcelo Fernández, Nicole Lecot, Pablo Cabral, Francesç Teixidor, Clara Viñas, Hugo Cerecetto · 2019 · Future Medicinal Chemistry
11. Transcriptional activation of SIRT6 via FKHRL1/FOXO3a inhibits the Warburg effect in glioblastoma cells
    Zhen Dong, Xiaoxia Zhong, Qian Lei, Fei Chen, Hongjuan Cui · 2019 · Cellular Signalling
12. The Nomogram of MRI ‐based Radiomics with Complementary Visual Features by Machine Learning Improves Stratification of Glioblastoma Patients: A Multicenter Study
    Yuyun Xu, Xiaodong He, Yumei Li, Peipei Pang, Zhenyu Shu, Xiangyang Gong · 2021 · Journal of Magnetic Resonance Imaging
13. β-Asarone promotes Temozolomide’s entry into glioma cells and decreases the expression of P-glycoprotein and MDR1
    Nanbu Wang, Qinxin Zhang, Baile Ning, Laiyu Luo, Yongqi Fang · 2017 · Biomedicine & Pharmacotherapy
14. Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line
    Roberta Milani, Eleonora Brognara, Enrica Fabbri, Alessia Finotti, Monica Borgatti, Ilaria Lampronti, Giovanni Marzaro, Adriana Chilin, Kenneth K. Lee, Stanton Kok et al. · 2017 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
15. Rational design of siRNA-based delivery systems for effective treatment of brain diseases
    Dailin Lu, Yonghang Sun, Yuxia Luan, Wenxiu He · 2024 · Pharmaceutical Science Advances
16. Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data
    Dimitra Smerdi, Myrto K. Moutafi, Ioannis Kotsantis, Lampis C. Stavrinou, Amanda K. Psyrri · 2024 · Life
17. The post-surgical era of GBM: How molecular biology has impacted on our clinical management. A review
    Matteo Monticelli, Pietro Zeppa, Francesco Zenga, Roberto Altieri, Marco Mammi, Luca Bertero, Isabella Castellano, Paola Cassoni, Antonio Melcarne, Giuseppe La Rocca et al. · 2018 · Clinical Neurology and Neurosurgery
18. MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma
    Mahsa Palizkaran Yazdi, Amirhosein Barjasteh, Meysam Moghbeli · 2024 · Molecular Brain
19. Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery
    Xin-Qi Teng, Jian Qu, Guohua Li, Hai-Hui Zhuang, Qiang Qu · 2022 · Frontiers in Cell and Developmental Biology
20. Heat Shock Factor 1 Depletion Sensitizes A172 Glioblastoma Cells to Temozolomide via Suppression of Cancer Stem Cell-Like Properties
    Chang‐Nim Im, Hye Jung Yun, Jeong Hwa Lee · 2017 · International Journal of Molecular Sciences
21. Aptamer-functionalized nanoplatforms overcoming temozolomide resistance in synergistic chemo/photothermal therapy through alleviating tumor hypoxia
    Yun Zeng, Linfei Zhao, Ke Li, Jingwen Ma, Dan Chen, Changhu Liu, Wenhua Zhan, Yonghua Zhan · 2023 · Nano Research
22. Brain-targeting redox-sensitive micelles for codelivery of TMZ and β-lapachone for glioblastoma therapy
    Yuxiang Dai, Yuanping Min, Zhou Lu, Longyang Cheng, Hongbin Ni, Yang Yang, Wendi Zhou · 2024 · Nanomedicine Nanotechnology Biology and Medicine
23. A novel polysaccharide derived from algae extract inhibits cancer progression via JNK, not via the p38�MAPK signaling pathway
    Peiyu Xie, Fukuko Horio, Isao Fujii, Ji-en Zhao, Makoto Shinohara, Makoto Matsukura · 2018 · International Journal of Oncology
24. Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances Cell Growth by Retrieving PIM1 From miR-761
    Wei Wang, Shuai Han, Wei Gao, Feng Yuan, Kunhang Li, Di Wu · 2020 · Cellular and Molecular Neurobiology
25. Implication of Lactucopicrin in Autophagy, Cell Cycle Arrest and Oxidative Stress to Inhibit U87Mg Glioblastoma Cell Growth
    Rossella Rotondo, Maria Antonietta Oliva, Sabrina Staffieri, Salvatore Castaldo, Felice Giangaspero, Antonietta Arcella · 2020 · Molecules
26. The role and clinical relevance of long non-coding RNAs in glioma
    Гареев Ильгиз Фанилевич, Manuel De Jesus Encarnación Ramírez, Renat Madekhatovich Nurmukhametov, Denis Ivliev, Alina V. Shumadalova, Tatiana Ilyasova, Aferin Beilerli, Chunlei Wang · 2023 · Non-coding RNA Research
27. MicroRNA‑30a increases the chemosensitivity of U251 glioblastoma cells to temozolomide by directly targeting beclin�1 and inhibiting autophagy
    Jing Xu, He Huang, Renjun Peng, Xiping Ding, Bing‐Hua Jiang, Xianrui Yuan, Jian Xi · 2018 · Experimental and Therapeutic Medicine
28. miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin Via Regulation Of SOS1
    Meihua Wang, Qi Wu, Mingming Fang, Wu Huang, Hong Zhu · 2019 · OncoTargets and Therapy · Retracted
29. Human Glioma Cells Acquire Temozolomide Resistance After Repeated Drug Exposure Via DNA Mismatch Repair Dysfunction
    Kei Yamashiro, Kazutaka Nakao, Shigeo Ohba, Yuichi Hirose · 2020 · Anticancer Research
30. Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma
    Natasha Carmell, Ola Rominiyi, Katie N. Myers, Connor L McGarrity-Cottrell, Aurelie Vanderlinden, Nikita Lad, Eva Perroux-David, Sherif F. El‐Khamisy, Malee S Fernando, Katherine G. Finegan et al. · 2021 · Cancers
31. Towards tailored management of malignant brain tumors with nanotheranostics
    Juan Aparicio-Blanco, Ana Isabel Torres‐Suárez · 2018 · Acta Biomaterialia
32. ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide
    Annika Malmström, M Łysiak, Lisa Åkesson, Ingrid Jakobsen Falk, Munila Mudaisi, Peter Milos, Martin Hallbeck, Victoria Fomichov, Helle Broholm, Kirsten Grunnet et al. · 2019 · The Pharmacogenomics Journal
33. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP3R1/AKT/β-catenin pathway
    Youxiang Ding, You Lang Zhou, Zhaohe Li, Heng Zhang, Yue Yang, Hongkun Qin, Qingxiang Xu, Li Zhao · 2020 · Life Sciences
34. Nogo receptor–vimentin interaction: a novel mechanism for the invasive activity of glioblastoma multiforme
    Yun Hee Kang, Seung Ro Han, Hyungtaek Jeon, Suhyuk Lee, Jisu Lee, Seung‐Min Yoo, Myung‐Jin Park, Myung-Jin Park, Jong‐Tae Kim, Myung‐Shin Lee et al. · 2019 · Experimental & Molecular Medicine
35. Cedrus atlantica Extract Suppress Glioblastoma Growth through Promotion of Genotoxicity and Apoptosis: In Vitro and In Vivo Studies
    Kai‐Fu Chang, Jinghua Tsai Chang, Xiao‐Fan Huang, Ya‐Chih Huang, Chia‐Yu Li, Jun‐Cheng Weng, Chih‐Yen Hsiao, Hui-Ju Hsu, Nu‐Man Tsai · 2021 · International Journal of Medical Sciences
36. Microneedle Patch Delivery of PLCG1-siRNA Efficient Enhanced Temozolomide Therapy for Glioblastoma
    Zhipeng Yang, Yanjie Liu, Haoyuan Li, Qisheng Tang, Biao Yang, Zhifeng Shi, Ying Qing Mao · 2024 · Biomacromolecules
37. The effect of polysaccharides from Cibotium barometz on enhancing temozolomide–induced glutathione exhausted in human glioblastoma U87 cells, as revealed by 1H NMR metabolomics analysis
    Yue Shi, Xiao Wang, Ning Wang, Feifei Li, Yu‐Lin You, Shuqi Wang · 2020 · International Journal of Biological Macromolecules
38. Inhibition of Intermedin (Adrenomedullin 2) Suppresses the Growth of Glioblastoma and Increases the Antitumor Activity of Temozolomide
    Lüping Huang, Denian Wang, Zhongxue Feng, Huan Zhao, Fei Xiao, Yong'gang Wei, Heng Zhang, Hongyu Li, Lingmiao Kong, Min Li et al. · 2020 · Molecular Cancer Therapeutics
39. Restoring chemo-sensitivity to temozolomide via targeted inhibition of poly (ADP-ribose) polymerase-1 by naringin in glioblastoma
    Vanishree Rao, Sri Pragnya Cheruku, Suman Manandhar, R. J. A. Vibhavari, Krishnadas Nandakumar, C. Mallikarjuna Rao, V. Ravichandiran, Nitesh Kumar · 2021 · Chemical Papers
40. Characterization of Byproducts from Chemical Syntheses of Oligonucleotides Containing 1-Methyladenine and 3-Methylcytosine
    Qi Tang, Ang Cai, Ke Bian, Fangyi Chen, James C. Delaney, Sravani Adusumalli, A. Bach, Fatemeh Akhlaghi, Bongsup P. Cho, Deyu Li · 2017 · ACS Omega
41. β-asarone induces cell apoptosis, inhibits cell proliferation and decreases migration and invasion of glioma cells
    Nanbu Wang, Yufeng Han, Laiyu Luo, Qinxin Zhang, Baile Ning, Yongqi Fang · 2018 · Biomedicine & Pharmacotherapy
42. Cell-Free Circulating Epimarks in Cancer Monitoring
    Manon Duforestel, Joséphine Briand, Gwenola Bougras-Cartron, Dominique Heymann, Jean‐Sébastien Frenel, François M. Vallette, Pierre‐François Cartron · 2020 · Epigenomics
43. The interruption of atypical PKC signaling and Temozolomide combination therapy against glioblastoma
    Avijit Dey, S.M. Anisul Islam, Rekha S Patel, Mildred E. Acevedo-Duncan · 2020 · Cellular Signalling
44. In Vitro Radiosensitizing Effects of Temozolomide on U87MG Cell Lines of Human Glioblastoma Multiforme.
    Samira Borhani, Hossein Mozdarani, Somayyeh Babalui, Mohsen Bakhshandeh, Hassan Nosrati · 2017 · PubMed Central
45. The miR-429 suppresses proliferation and migration in glioblastoma cells and induces cell-cycle arrest and apoptosis via modulating several target genes of ERBB signaling pathway
    Fatemeh Gheidari, Ehsan Arefian, Fatemeh Saadatpour, Mahboubeh Kabiri, Ehsan Seyedjafari, Ladan Teimoori‐Toolabi, Masoud Soleimani · 2022 · Molecular Biology Reports
46. Artificial microenvironment of in vitro glioblastoma cell cultures changes profile of miRNAs related to tumor drug resistance
    Monika Witusik‐Perkowska, Magdalena Zakrzewska, Dariusz Jan Jaskólski, Pawel Piotr Liberski, Janusz Szemraj · 2019 · OncoTargets and Therapy
47. Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization
    Ahmet Cingöz, Ezgi Ozyerli‐Goknar, Tunç Morova, Fidan Seker-Polat, Myvizhi Esai Selvan, Zeynep Hulya Gumus, Deepak Bhere, Khalid Shah, İhsan Solaroğlu, Tugba Bagci Onder · 2021 · Oncogene
48. Inhibition of FAM83D displays antitumor effects in glioblastoma via down‐regulation of the AKT /Wnt/β‐catenin pathway
    Jubo Wang, Yu Hua Quan, Jian Lv, Shouping Gong, Pengyu Ren · 2022 · Environmental Toxicology
49. ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide
    Lara H. El Touny, Curtis D. Hose, John Connelly, Erik D. Harris, Anne P. Monks, Angie B. Dull, Deborah F. Wilsker, Melinda G. Hollingshead, Michelle M. Gottholm-Ahalt, Sergio Y. Alcoser et al. · 2021 · Oncotarget
50. Drug metabolism-related gene ABCA1 augments temozolomide chemoresistance and immune infiltration abundance of M2 macrophages in glioma
    Yuanliang Yan, Yuanhong Liu, Qiuju Liang, Zhijie Xu · 2023 · European journal of medical research
51. Emerging trends in cell-based therapies: contemporary advances and ethical considerations in translational neurosurgical oncology
    Matthew Alexander Abikenari, Justin Liu, Joseph H. Ha, Shreyas Annagiri, Vratko Himič, Ravi Teja Medikonda, Lily H. Kim, John Hyunkuk Choi, Michael K. Lim · 2025 · Journal of Neuro-Oncology
52. Controlled release of carnosine from poly(lactic- co -glycolic acid) beads using nanomechanical magnetic trigger towards the treatment of glioblastoma
    Kinana Habra, R.H. Morris, Stéphanie McArdle, Gareth W. V. Cave · 2022 · Nanoscale Advances
53. Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma
    Ann‐Christin Nickel, Xueyan Wan, Dino Vitali Saban, Yinlun Weng, Shu Zhang, Kathy Keyvani, Ulrich Sure, Yuan Zhu · 2018 · Journal of Neuro-Oncology
54. Temozolomide-Induced RNA Interactome Uncovers Novel LncRNA Regulatory Loops in Glioblastoma
    Sabrina Fritah, Arnaud Muller, Wei Jiang, Ramkrishna Mitra, Mohamad Sarmini, Monika Dieterle, Anna Golebiewska, Tao Ye, Eric Van Dyck, Christel C. Herold‐Mende et al. · 2020 · Cancers
55. Role of microRNAs in tumor progression by regulation of kinesin motor proteins
    Arya Nasimi Shad, Ali Fanoodi, Amirhosein Maharati, Iman Akhlaghipour, Amir Reza Bina, Ehsan Saburi, Fatemeh Forouzanfar, Meysam Moghbeli · 2024 · International Journal of Biological Macromolecules
56. Modelling glioblastoma resistance to temozolomide. A mathematical model to simulate cellular adaptation in vitro
    Marina Pérez-Aliacar, Jacobo Ayensa-Jiménez, Teodora Ranđelović, Ignacio Ochoa, M. Doblaré · 2024 · Computers in Biology and Medicine
57. Disentangling the therapeutic tactics in GBM: From bench to bedside and beyond
    S. Daisy Precilla, Shreyas S. Kuduvalli, T. S. Anitha · 2020 · Cell Biology International
58. NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma
    Guangrong Zheng, Han Tao, Xiaomu Hu, Yang Zhou, Jin Wang, Zhenyi Wen, Hengyu Li, Hongjin Wang · 2022 · Frontiers in Oncology
59. CREB-induced LINC00473 promotes chemoresistance to TMZ in glioblastoma by regulating O6-methylguanine-DNA-methyltransferase expression via CEBPα binding
    Liya Jiang, Guan-Hao Wang, Jing-Jiao Xu, Xiaoli Li, Xiaoyan Lin, Xiang Fang, Hongxu Zhang, Mei Feng, Chunming Jiang · 2023 · Neuropharmacology
60. Smarcd1 Inhibits the Malignant Phenotypes of Human Glioblastoma Cells via Crosstalk with Notch1
    Yihao Zhu, Handong Wang, Maoxing Fei, Ting Fang Tang, Wenhao Niu, Li Zhang · 2020 · Molecular Neurobiology
61. A Synopsis of Biomarkers in Glioblastoma: Past and Present
    Ligia Gabriela Tătăranu, Șerban Turliuc, Radu Eugen Rizea, Anica Dricu, Oana Alexandru, Georgiana-Adeline Staicu, Amira Kamel · 2024 · Current Issues in Molecular Biology
62. Chaperone protein P4HB predicts temozolomide response and prognosis in malignant glioma
    Stella Sun, Karrie Mei Yee Kiang, Gkk Leung · 2022 · Oncology Letters
63. Natural Products Targeting Hsp90 for a Concurrent Strategy in Glioblastoma and Neurodegeneration
    Sarmistha Mitra, Raju Dash, Yeasmin Akter Munni, Nusrat Jahan Selsi, Nasrin Akter, Md. Nazim Uddin, Kishor Mazumder, Il Soo Moon · 2022 · Metabolites
64. Downregulation of BASP1 Promotes Temozolomide Resistance in Gliomas via Epigenetic Activation of the FBXO32/NF-κB/MGMT Axis
    Xinyi Liao, Ziwen Li, Haiqing Zheng, Wanying Qian, Shuxia Zhang, Suwen Chen, Xincheng Li, Miaoling Tang, Yingru Xu, Ruyuan Yu et al. · 2023 · Molecular Cancer Research
65. RLIP76 Depletion Enhances Autophagic Flux in U251 Cells
    Chenran Zhang, Zheng Cai, Qiang Liang, Qi Wang, Yicheng Lu, Liuhua Hu, Guohan Hu · 2016 · Cellular and Molecular Neurobiology
66. Identification of 2-Fluoropalmitic Acid as a Potential Therapeutic Agent Against Glioblastoma
    Shabierjiang Jiapaer, Takuya Furuta, Yu Hao Dong, Tomohiro Kitabayashi, Hemragul Sabit, Jiakang Zhang, Guangtao Zhang, Shingo Tanaka, Masahiko Kobayashi, Atsushi Hirao et al. · 2020 · Current Pharmaceutical Design
67. RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastoma
    Anna M. Jermakowicz, Alison Kurimchak, Katherine J. Johnson, Florence Bourgain‐Guglielmetti, Simon Kaeppeli, Maurizio Affer, Hari Pradhyumnan, Robert K. Suter, Winston M. Walters, Maria L. Cepero et al. · 2024 · Scientific Reports
68. Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT
    Manmeet Singh Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng, Matthew Lee, Sanhita Rath, Harshil Dhruv, Yue Hao, Michael E. Berens et al. · 2024 · Clinical Cancer Research
69. WZY‑321, a novel evodiamine analog, inhibits glioma cell growth in an autophagy‑associated manner
    Guan Sun, Chuang Zhang, Hongmao Song, Jun Guo, Min Li, Ying Cao · 2018 · Oncology Letters
70. Pretreatment structural and arterial spin labeling MRI is predictive for p53 mutation in high-grade gliomas
    Jiaji Mao, Dabiao Deng, Zehong Yang, Wensheng Wang, Minghui Cao, Yun Huang, Jun Shen · 2020 · British Journal of Radiology
71. Overexpression of TELO2 decreases survival in human high-grade gliomas
    Shao-Wei Feng, Ying Chen, Wen‐Chiuan Tsai, Hsin-Ying Clair Chiou, Sheng‐Tang Wu, Li‐Chun Huang, Chin S. Lin, Chih-Chuan Hsieh, Yun‐Ju Yang, Dueng‐Yuan Hueng · 2016 · Oncotarget
72. Markedly divergent effects of Ouabain on a Temozolomide-resistant (T98G) vs. a Temozolomide-sensitive (LN229) Glioblastoma cell line
    Heidrun Weidemann, Daniel Feger, Jan E. Ehlert, Marcus Menger, Robert C Krempien · 2023 · Discover Oncology
73. Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity
    Dorival Mendes Rodrigues‐Junior, Cristiano Raminelli, Haifa Hassanie, Gustavo Henrique Goulart Trossini, Givago Prado Perecim, Laia Caja, Aristidis Moustakas, Andre Luiz Vettore · 2022 · Scientific Reports
74. Next Generation of Brain Cancer Nanomedicines to Overcome the Blood–Brain Barrier (BBB): Insights on Transcytosis, Perivascular Tumor Growth, and BBB Models
    Gizem Bor, Leticia Hosta‐Rigau · 2023 · Advanced Therapeutics
75. Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma
    Filiz Senbabaoglu, Ali Cenk Aksu, Ahmet Cingöz, Fidan Seker-Polat, Esra Börklü, İhsan Solaroğlu, Tugba Bagci Onder · 2020 · Frontiers in Neuroscience
76. The Long Non-Coding RNA HOXC-AS3 Promotes Glioma Progression by Sponging miR-216 to Regulate F11R Expression
    Yongshuai Li, Peng Lu, Xianwen Cao, Kun Yang, Zhen Wang, Yong Xiao, Hong Xiao, Chunfa Qian, Hongyi Liu · 2022 · Frontiers in Oncology
77. Alkaloids of fascaplysin are promising chemotherapeutic agents for the treatment of glioblastoma: Review
    Irina Lyakhova, Mariia A. Piatkova, Valeriia S. Gulaia, Alexander O. Romanishin, Mikhail E. Shmelev, Andrey S. Bryukhovetskiy, Aruna Sharma, Hari Shanker Sharma, Rodion Khotimchenko, Igor Bryukhovetskiy · 2020 · International review of neurobiology
78. Olaparib: A Chemosensitizer for the Treatment of Glioblastoma
    Naresh Dhanavath, Priya Bisht, Mohini Santosh Jamadade, Krishna Murti, Pranay Wal, Nitesh Kumar · 2024 · Mini-Reviews in Medicinal Chemistry
79. Anlotinib as Monotherapy or Combination Therapy for Recurrent High-Grade Glioma: A Retrospective Study
    Jun Yin, Wenya Yin, Linlin Zheng, Yimin Li, Cheng Luo, Shuo Zhang, Lei Duan, Hang Zhou, Kai Cheng, Jinyi Lang et al. · 2023 · Clinical Medicine Insights Oncology
80. Temozolomide and flavonoids against glioma: from absorption and metabolism to exosomal delivery
    Priyanka Verma, Hemant Joshi, Tejveer Singh, Bunty Sharma, Ujjawal Sharma, Seema Ramniwas, Rashmi Rana, Madhu Gupta, Ginpreet Kaur, Hardeep Singh Tuli · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
81. BTN2A2, a new biomarker and therapeutic target for glioma
    Heping Wang, Shanrui Pu, Haitao Xu, Lihong Yang, Lishi Shao, Xi Chen, Xiaobin Huang, Jun Pu · 2023 · Aging
82. Valproic acid regulates the miR-155/Jarid2 axis by affecting miR-155 promoter methylation in glioma
    Ruixuan Wang, Yanhong Chen, Weilu Kuang, Wuzhong Jiang, Wenjing Zeng, Yinyun Chen, Zhengzheng Liu · 2023 · Acta Biochimica et Biophysica Sinica
83. New Gemcitabine Derivatives as Potent in vitro α-Glucosidase Inhibitors
    Farked Wahoodi Salman, Ahmed Jasim Twayej, Hayder Ahmed Shaheed, Ali Jabbar Radhi · 2019 · Nano Biomedicine and Engineering
84. The Effect of Glioblastoma on Pericytes
    Maria Luisa Molina, Rut Valdor · 2020 · Current Tissue Microenvironment Reports
85. Exploring the Functional Roles of Telomere Maintenance 2 in the Tumorigenesis of Glioblastoma Multiforme and Drug Responsiveness to Temozolomide
    Shao-Wei Feng, Zih-Syuan Wu, Yi‐Lin Chiu, Shih‐Ming Huang · 2023 · International Journal of Molecular Sciences
86. Managing CNS Tumors: The Nanomedicine Approach
    Juan Aparicio-Blanco, Ana Isabel Torres‐Suárez · 2017 · InTech eBooks
87. Adult IDH Wild-Type Glioblastoma Ultrastructural Investigation Suggests a Possible Correlation between Morphological Biomarkers and Ki-67 Index
    Pietro Familiari, Michela Relucenti, Pierfrancesco Lapolla, Mauro Palmieri, Manila Antonelli, Loredana Cristiano, Claudio Barbaranelli, Myriam Catalano, Luca D’Angelo, Giuseppe Familiari et al. · 2023 · Biomedicines
88. Polymer–Drug Conjugates Codeliver a Temozolomide Intermediate and Nitric Oxide for Enhanced Chemotherapy against Glioblastoma Multiforme
    Ke Du, Xiao Li, Fude Feng · 2024 · ACS Applied Bio Materials
89. AHR, a novel inhibitory immune checkpoint receptor, is a potential therapeutic target for chemoresistant glioblastoma
    Nian Tan, Wei Zhao, Yiyang Wang, Ping Li, Jianwei Liu, Zhaoying Sun, Jianming Pan, Shilin Song, Shunyao Li, Ziyi Liu et al. · 2023 · Journal of Cancer Research and Clinical Oncology
90. Transcriptomic analysis identifies the neuropeptide cortistatin (CORT) as an inhibitor of temozolomide (TMZ) resistance by suppressing the NF-κB-MGMT signaling axis in human glioma
    Zongze He, Bo Peng, Qi Wang, Jie Tian, Ping Liu, Jie Feng, Yiwei Liao, Longyi Chen, Ping Jia, Jian Tang · 2023 · Genes & Diseases
91. Glioblastoma: a molecular genetic portrait and modern therapeutic strategies for drug treatment
    Gelena P. Guens, Varvara D. Sanikovich, Vladislav Mileyko, Alexandra Lebedeva · 2021 · Advances in molecular oncology
92. Galectins: a promising arsenal of novel immunotherapeutic weapons in oncology tunned by an array of non-coding RNAs
    Alyaa Dawoud, Tasneem Abaza, Yomna Youssef, Dana Ahmed Seada, Adham H. Mohamed, Mai F. Ragab, Jana Mohamed Fahmy, Hana El Hassan El Masry, Mary George Sabry, Marola Paula Fawzy et al. · 2025 · Critical Reviews in Biochemistry and Molecular Biology
93. Predicting temozolomide response in low-grade glioma patients with large-scale machine learning
    Hanqin Du, Chayanit Piyawajanusorn, Ghita Ghislat, Pedro J. Ballester · 2025 · BMC Methods
94. Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis
    Wang Chen, Pida Hao, Qile Song, Xiaotong Feng, Xuan Zhao, Jincheng Wu, Zixiang Gong, Jinli Zhang, Xiaoyan Fu, Xianjun Wang · 2024 · Metabolic Brain Disease
95. Proteomic Analysis Uncovers Enhanced Inflammatory Phenotype and Distinct Metabolic Changes in IDH1 Mutant Glioma Cells
    Sigrid Ravn Berg, Alessandro Brambilla, Lars Hagen, Animesh Sharma, Cathrine Broberg Vågbø, Nina‐Beate Liabakk, Miroslava Kiššová, Miquel Arano Barenys, Magnar Bjørås, SVERRE HELGE TORP et al. · 2025 · International Journal of Molecular Sciences
96. Glioblastoma: Molecular profile and immunophenotypic analysis as prognostic tools for tailored therapy and decision making in a recent surgical series
    Maurizio Salvati, Leonardo Tariciotti, Giacoma Maria Floriana Brunetto, Gaetano Gallo, Francesca Santoro, Alessandro Frati, Antonio Santoro · 2020 · Interdisciplinary Neurosurgery
97. Galectin-1 Expression Is Associated with the Response and Survival Following Preoperative Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
    Shau-Hsuan Li, Yen‐Hao Chen, Hung‐I Lu, Chien-Ming Lo, Chao‐Cheng Huang, Yu‐Ming Wang, Eng‐Yen Huang · 2021 · Cancers
98. Effect of Foretinib on Matrix Metalloproteinase-2 (MMP2) Expression in Glioblastoma
    Maryam Fotoohi, Nasrin Hadi, Faezeh Namazi · 2019 · Research in Molecular Medicine
99. WNT vampirization by glioblastoma leads to tumor growth and neurodegeneration
    Marta Portela, Varun Venkataramani, Natasha Fahey-Lozano, Esther Seco, María Losada‐Pérez, Frank Winkler, Sergio Casas‐Tintó · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
100. Neuropilin‐1 enhances temozolomide resistance in glioblastoma via the STAT1/p53/p21 axis
     Ping Huang, Lixia Zhang, Hongwei Wang, Changwu Dou, Haitao Ju, Peng Yue, Jiaxing Ren · 2024 · Neuropathology